Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emmessar Biotech & Nutrition has informed that it enclosed the newspaper clippings regarding the intimation of Board Meeting, to be held on Thursday, August 10, 2023 at 12:00 Noon, published in The Free Press Journal in English and Navshakti in Marathi, dated July 13, 2023.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1689.10 |
| Dr. Reddys Lab | 1221.40 |
| Cipla | 1239.90 |
| Zydus Lifesciences | 946.80 |
| Lupin | 2333.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: